Lp(a): what is a good level?
Lp(a) is not part of a standard lipid panel and is rarely measured unless specifically requested. Where it is reported, thresholds around 75 nmol/L (roughly 30 mg/dL) are commonly used to flag elevation.
This is the range used by the atherogenic dial in the Longevity Score calculator. It is deliberately tighter than the range printed on a standard lab report — the reasoning is below.
Nothing you type here is sent anywhere, stored, or logged. It never leaves this page.
Here the two agree: the optimised target and the standard cutoff are the same. What a standard report leaves out is not the threshold but the context — which is the rest of this page.
What Lp(a) actually measures
Lp(a) is an LDL particle with an additional protein, apolipoprotein(a), attached. That addition makes it both atherogenic and prothrombotic — it contributes to plaque and to clot formation.
Your level is roughly 80–90% genetically determined, set at birth and largely stable through life. It is a constraint rather than a variable.
Why it matters
Roughly one in five people carries an elevated level, and most of them do not know, because the test is not routine.
It is an independent risk factor — meaning it adds risk on top of whatever your LDL or ApoB happens to be. It is a common explanation for cardiovascular events in people whose standard lipid panel looked unremarkable.
It is also the single strongest argument for measuring it once: the result changes how aggressively everything else is worth managing.
Why it's on the dashboard
Lp(a) made the panel because it is the single biggest blind spot in a standard lipid panel — roughly one in five people carries an elevated, largely genetic level, and almost none of them know it, because the test is not routine. The lifespan case is strong: in the Copenhagen City Heart Study, Kamstrup et al. (JAMA, 2009) found people in the top few percent of the Lp(a) distribution had three- to four-fold higher rates of myocardial infarction than those at the bottom, with no threshold below which the risk stopped rising. The healthspan case is distinct from heart-attack risk and often overlooked: Thanassoulis et al. (New England Journal of Medicine, 2013) found the same gene variants that raise Lp(a) independently raise the risk of aortic valve calcification and the eventual need for valve replacement — a separate, disabling condition years before any heart attack would occur. It belongs to the atherogenic dial because that dial tracks how much material is circulating that could be retained and do damage, and Lp(a) is the one marker on this panel where that exposure is set mostly at birth rather than by anything you did. See the Atherogenic dial for the broader context.
Why this range is stricter than your lab's
Because risk rises continuously with concentration rather than at a threshold, any single cut-point is a convenience. Lower is better across the range.
The practical difference is not in the number but in what follows from it. An elevated result does not mean treating Lp(a) itself; it means treating modifiable risk — particularly ApoB and blood pressure — with more urgency.
This distinction applies across the whole panel, not just this marker — see optimal versus standard lab ranges for the general case.
What moves Lp(a)
Educational information, not a treatment plan. Discuss changes to medication or supplementation with a clinician who knows your history.
How fast it responds
Stable for life. Measure once; there is no value in repeating it unless the assay or units change. See response times across all markers for how this compares.
What can distort the result
- Units matter. nmol/L and mg/dL are not interchangeable and the conversion is not exact, because particle size varies between people. Compare like with like.
- Levels can rise modestly with inflammation and with kidney disease, and fall somewhat with hormone therapy.
Frequently asked questions
What is a good Lp(a) level?
The longevity-optimised target used in this calculator is < 30 nmol/L. Lp(a) is not part of a standard lipid panel and is rarely measured unless specifically requested. Where it is reported, thresholds around 75 nmol/L (roughly 30 mg/dL) are commonly used to flag elevation.
Why is this target stricter than the range on my lab report?
Because risk rises continuously with concentration rather than at a threshold, any single cut-point is a convenience. Lower is better across the range.
How fast does Lp(a) respond to change?
Stable for life. Measure once; there is no value in repeating it unless the assay or units change.
Related markers
Lp(a) feeds the atherogenic dial, and read it alongside ApoB · hs-CRP.